Current Use of Prophylactic Strategies for Postoperative Atrial Fibrillation: A Survey of Canadian Cardiac Surgeons

Joel Price, Rebecca Tee, Buu Khanh Lam, Paul Hendry, Martin S. Green, Fraser D. Rubens

Research output: Contribution to journalArticle

Abstract

Background: Evidence from multiple trials demonstrates the efficacy of prophylactic β-blocker, amiodarone, and corticosteroid administration in reducing the incidence of postoperative atrial fibrillation. Despite this information, these interventions remain infrequently or inappropriately utilized. This study was designed to assess the frequency with which these prophylactic strategies are currently being used and to identify concerns and barriers to more widespread application. Methods: A link to an online survey was e-mailed to all practicing cardiac surgeons in Canada. Each surgeon was given a unique log-in identification number to complete the survey online through a secure web page. Results: Surveys were sent to 166 surgeons; 119 completed surveys (72%) were returned. Only 58% of respondents routinely use β-blockade for prophylaxis. For nonusers, 44% are unconvinced of the evidence for this practice. The routine use of amiodarone among surgeons was 19%. Of the remainder, 43% cited a perceived increased risk of complications as the reason for not using this therapy. An additional 29% considered the therapy was excessively complicated or time consuming. Corticosteroids were routinely used by only one surgeon. Major barriers to use of steroids were unconvincing evidence (76%), a perceived increased risk of wound infection (38%), and hyperglycemia (30%). Conclusions: Despite level 1 evidence, the use of β-blockers, amiodarone, and corticosteroids for prophylaxis of atrial fibrillation among Canadian surgeons remains less than expected. The results of this survey support the need for further clinical trials with robust and clinically relevant outcomes that may further influence surgeons to adopt this practice.

Original languageEnglish (US)
Pages (from-to)106-110
Number of pages5
JournalAnnals of Thoracic Surgery
Volume88
Issue number1
DOIs
StatePublished - Jul 2009
Externally publishedYes

Fingerprint

Atrial Fibrillation
Amiodarone
Adrenal Cortex Hormones
Wound Infection
Surveys and Questionnaires
Surgeons
Hyperglycemia
Canada
Steroids
Clinical Trials
Incidence
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Current Use of Prophylactic Strategies for Postoperative Atrial Fibrillation : A Survey of Canadian Cardiac Surgeons. / Price, Joel; Tee, Rebecca; Lam, Buu Khanh; Hendry, Paul; Green, Martin S.; Rubens, Fraser D.

In: Annals of Thoracic Surgery, Vol. 88, No. 1, 07.2009, p. 106-110.

Research output: Contribution to journalArticle

Price, Joel ; Tee, Rebecca ; Lam, Buu Khanh ; Hendry, Paul ; Green, Martin S. ; Rubens, Fraser D. / Current Use of Prophylactic Strategies for Postoperative Atrial Fibrillation : A Survey of Canadian Cardiac Surgeons. In: Annals of Thoracic Surgery. 2009 ; Vol. 88, No. 1. pp. 106-110.
@article{3608f2a96bd0409f92cfa315e24729d0,
title = "Current Use of Prophylactic Strategies for Postoperative Atrial Fibrillation: A Survey of Canadian Cardiac Surgeons",
abstract = "Background: Evidence from multiple trials demonstrates the efficacy of prophylactic β-blocker, amiodarone, and corticosteroid administration in reducing the incidence of postoperative atrial fibrillation. Despite this information, these interventions remain infrequently or inappropriately utilized. This study was designed to assess the frequency with which these prophylactic strategies are currently being used and to identify concerns and barriers to more widespread application. Methods: A link to an online survey was e-mailed to all practicing cardiac surgeons in Canada. Each surgeon was given a unique log-in identification number to complete the survey online through a secure web page. Results: Surveys were sent to 166 surgeons; 119 completed surveys (72{\%}) were returned. Only 58{\%} of respondents routinely use β-blockade for prophylaxis. For nonusers, 44{\%} are unconvinced of the evidence for this practice. The routine use of amiodarone among surgeons was 19{\%}. Of the remainder, 43{\%} cited a perceived increased risk of complications as the reason for not using this therapy. An additional 29{\%} considered the therapy was excessively complicated or time consuming. Corticosteroids were routinely used by only one surgeon. Major barriers to use of steroids were unconvincing evidence (76{\%}), a perceived increased risk of wound infection (38{\%}), and hyperglycemia (30{\%}). Conclusions: Despite level 1 evidence, the use of β-blockers, amiodarone, and corticosteroids for prophylaxis of atrial fibrillation among Canadian surgeons remains less than expected. The results of this survey support the need for further clinical trials with robust and clinically relevant outcomes that may further influence surgeons to adopt this practice.",
author = "Joel Price and Rebecca Tee and Lam, {Buu Khanh} and Paul Hendry and Green, {Martin S.} and Rubens, {Fraser D.}",
year = "2009",
month = "7",
doi = "10.1016/j.athoracsur.2009.03.059",
language = "English (US)",
volume = "88",
pages = "106--110",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Current Use of Prophylactic Strategies for Postoperative Atrial Fibrillation

T2 - A Survey of Canadian Cardiac Surgeons

AU - Price, Joel

AU - Tee, Rebecca

AU - Lam, Buu Khanh

AU - Hendry, Paul

AU - Green, Martin S.

AU - Rubens, Fraser D.

PY - 2009/7

Y1 - 2009/7

N2 - Background: Evidence from multiple trials demonstrates the efficacy of prophylactic β-blocker, amiodarone, and corticosteroid administration in reducing the incidence of postoperative atrial fibrillation. Despite this information, these interventions remain infrequently or inappropriately utilized. This study was designed to assess the frequency with which these prophylactic strategies are currently being used and to identify concerns and barriers to more widespread application. Methods: A link to an online survey was e-mailed to all practicing cardiac surgeons in Canada. Each surgeon was given a unique log-in identification number to complete the survey online through a secure web page. Results: Surveys were sent to 166 surgeons; 119 completed surveys (72%) were returned. Only 58% of respondents routinely use β-blockade for prophylaxis. For nonusers, 44% are unconvinced of the evidence for this practice. The routine use of amiodarone among surgeons was 19%. Of the remainder, 43% cited a perceived increased risk of complications as the reason for not using this therapy. An additional 29% considered the therapy was excessively complicated or time consuming. Corticosteroids were routinely used by only one surgeon. Major barriers to use of steroids were unconvincing evidence (76%), a perceived increased risk of wound infection (38%), and hyperglycemia (30%). Conclusions: Despite level 1 evidence, the use of β-blockers, amiodarone, and corticosteroids for prophylaxis of atrial fibrillation among Canadian surgeons remains less than expected. The results of this survey support the need for further clinical trials with robust and clinically relevant outcomes that may further influence surgeons to adopt this practice.

AB - Background: Evidence from multiple trials demonstrates the efficacy of prophylactic β-blocker, amiodarone, and corticosteroid administration in reducing the incidence of postoperative atrial fibrillation. Despite this information, these interventions remain infrequently or inappropriately utilized. This study was designed to assess the frequency with which these prophylactic strategies are currently being used and to identify concerns and barriers to more widespread application. Methods: A link to an online survey was e-mailed to all practicing cardiac surgeons in Canada. Each surgeon was given a unique log-in identification number to complete the survey online through a secure web page. Results: Surveys were sent to 166 surgeons; 119 completed surveys (72%) were returned. Only 58% of respondents routinely use β-blockade for prophylaxis. For nonusers, 44% are unconvinced of the evidence for this practice. The routine use of amiodarone among surgeons was 19%. Of the remainder, 43% cited a perceived increased risk of complications as the reason for not using this therapy. An additional 29% considered the therapy was excessively complicated or time consuming. Corticosteroids were routinely used by only one surgeon. Major barriers to use of steroids were unconvincing evidence (76%), a perceived increased risk of wound infection (38%), and hyperglycemia (30%). Conclusions: Despite level 1 evidence, the use of β-blockers, amiodarone, and corticosteroids for prophylaxis of atrial fibrillation among Canadian surgeons remains less than expected. The results of this survey support the need for further clinical trials with robust and clinically relevant outcomes that may further influence surgeons to adopt this practice.

UR - http://www.scopus.com/inward/record.url?scp=67649771391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649771391&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2009.03.059

DO - 10.1016/j.athoracsur.2009.03.059

M3 - Article

C2 - 19559204

AN - SCOPUS:67649771391

VL - 88

SP - 106

EP - 110

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 1

ER -